Visceral Leishmaniasis Mimicking Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Systemic Lupus Erythematosus Overlap
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In addition to typical clinical findings as fever, hepatosplenomegaly, and cachexia, VL is associated with autoimmune phenomena. To date, VL mimicking or exacerbating various autoimmune diseases have been described, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and autoimmune hepatitis (AIH). Herein, we presented a patient with VL who had overlapping clinical features with SLE, AIH, as well as antimitochondrial antibody (AMA-M2) positive primary biliary cirrhosis.
Abstract
Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In addition to typical clinical findings as fever, hepatosplenomegaly, and cachexia, VL is associated with autoimmune phenomena. To date, VL mimicking or exacerbating various autoimmune diseases have been described, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and autoimmune hepatitis (AIH). Herein, we presented a patient with VL who had overlapping clinical features with SLE, AIH, as well as antimitochondrial antibody (AMA-M2) positive primary biliary cirrhosis.
참고문헌 (15)
- Magıll AJ, "Leishmania species: visceral (kala-azar), cutaneus, and mucocutaneous leishmaniasis, In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases", pp.3463~3480 (2010), Churchill Livingston
- Herwaldt BL, "Leishmaniasis", Lancet, 354, pp.1191~1199 (1999)
- Ready PD, "Leishmaniasis emergence in Europe", Euro Surveill, 15, pp.19505~ (2010)
- Galvão-Castro B, "Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis", Clin Exp Immunol, 56, pp.58~66 (1984)
- Argov S, "Autoantibody production by patients infected with Leishmania", Clin Exp Immunol, 76, pp.190~197 (1989)
- Arlet JB, "Visceral leishmaniasis mimicking systemic lupus erythematosus", J Clin Rheumatol, 16, pp.203~204 (2010)
- Voulgari PV, "Visceral leishmaniasis resembling systemic lupus erythematosus", Ann Rheum Dis, 63, pp.1348~1349 (2004)
- Casato M, "Mixed cryoglobulinemia secondary to visceral leishmaniasis", Arthritis Rheum, 42, pp.2007~2011 (1999)
- Dalgic B, "A case of visceral leishmaniasis misdiagnosed as autoimmune hepatitis", Turk J Gastroenterol, 16, pp.52~53 (2005)
- Bern C, "Liposomal amphotericin B for the treatment of visceral leishmaniasis", Clin Infect Dis, 43, pp.917~924 (2006)
- Alioglu B, "Visceral leishmaniasis presented with Evans syndrome: A case report", Am J Hematol, 82, pp.1030~1031 (2007)
- Erduran E, "Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B", Pediatr Hematol Oncol, 22, pp.349~355 (2005)
- Yazici P, "Visceral leishmaniasis as a rare cause of granulomatosis hepatitis: A case report", Turkiye Parazitol Derg, 32, pp.12~15 (2008)
- Sakkas LI, "Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus", Clin Biochem, 41, pp.65~68 (2008)
- Atta AM, "Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody", J Autoimmun, 28, pp.55~58 (2007)